Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMUZP9V)

Drug Name
Src kinase inhibitor I Drug Info
Synonyms
Src Kinase Inhibitor I; 179248-59-0; Src I1; Src Inhibitor 1; Src I 1; Src Inhibitor-1; Src-l1; 6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine; SKI-1; CHEMBL97771; CHEBI:78332; 6,7-dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine; 4-Quinazolinamine, 6,7-dimethoxy-N-(4-phenoxyphenyl)-; 4-(4'-PHENOXYANILINO)-6,7-DIMETHOXYQUINAZOLINE; -Phenoxyanilino)-6,7-dimethoxyquinazoline; Src-I1; AC1LT1HN; Bionet1_003516; Oprea1_231056; GTPL6042; SCHEMBL1387206; KS-00002WRA; HMS578L18; CTK0E3319; AOB5689; DTXSID50363056
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
1474853
ChEBI ID
CHEBI:78332
CAS Number
CAS 179248-59-0
TTD Drug ID
DMUZP9V

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting RIP2 messenger RNA (RIP2 mRNA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-CRP DMQDUG4 Cardiovascular disease BA00-BE2Z Phase 1 [1]
NM-PP1 DMS8H5Q Discovery agent N.A. Investigative [1]
ISIS 104258 DMUC3L0 Discovery agent N.A. Investigative [2]
ISIS 104254 DMDEI9X Discovery agent N.A. Investigative [2]
ISIS 104211 DMPKQ61 Discovery agent N.A. Investigative [2]
ISIS 104257 DMSDCGV Discovery agent N.A. Investigative [2]
ISIS 104256 DMHUX9A Discovery agent N.A. Investigative [2]
ISIS 104255 DMAI5B8 Discovery agent N.A. Investigative [2]
ISIS 104253 DMME8JP Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
RIP2 messenger RNA (RIP2 mRNA) TTCQ2E5 RIPK2_HUMAN Inhibitor [1]

References

1 The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007 Dec 15;408(3):297-315.
2 US patent application no. 6,426,221, Antisense modulation of RIP2 expression.